Copyright
©The Author(s) 2022.
World J Clin Cases. May 6, 2022; 10(13): 4033-4041
Published online May 6, 2022. doi: 10.12998/wjcc.v10.i13.4033
Published online May 6, 2022. doi: 10.12998/wjcc.v10.i13.4033
All patients (n = 271) | Conventional CS group (n = 145) | Preventive CS group (n = 126) | P value | |
Male (n) | 156 (57.6%) | 95 (65.5%) | 61 (48.4%) | 0.489 |
Age (yr) | 47.7 ± 11.1 | 47.4 ± 11.4 | 48.1 ± 10.7 | 0.577 |
BMI (kg/m2) | 22.9 ± 3.8 | 23.2 ± 4.0 | 22.7 ± 3.7 | 0.407 |
Preoperative iPTH levels (pg/mL) | 1838.61 ± 933.60 | 1773.38 ± 934.49 | 1932.33 ± 928.01 | 0.143 |
Preoperative serum calcium amounts (mmol/L) | 2.58 ± 0.24 | 2.60 ± 0.25 | 2.55 ± 0.22 | 0.075 |
Preoperative serum phosphorus levels (mmol/L) | 2.24 ± 0.57 | 2.24 ± 0.60 | 2.22 ± 0.53 | 0.775 |
Preoperative calcium-phosphorus ratio | 5.75 ± 1.52 | 5.81 ± 1.58 | 5.67 ± 1.45 | 0.444 |
Preoperative ALP amounts (U/L) | 412.22 ± 415.14 | 409.18 ± 399.46 | 416.58 ± 438.28 | 0.878 |
- Citation: Liu J, Fan XF, Yang M, Huang LP, Zhang L. Effect of calcium supplementation on severe hypocalcemia in patients with secondary hyperparathyroidism after total parathyroidectomy. World J Clin Cases 2022; 10(13): 4033-4041
- URL: https://www.wjgnet.com/2307-8960/full/v10/i13/4033.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i13.4033